Outflow Area and Its Role in Glaucoma Pathogenesis

About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2007 - March 31, 2009
Grant ID
G2007013
Acknowledgement
Goals
This study seeks to understand the physical defects that occur in glaucomatous eyes prior to nerve injury and investigate whether these defects are reversible.
Summary
Glaucoma is typically associated with elevated intraocular pressure (IOP) caused by increased aqueous outflow resistance. In previous studies of bovine eyes, we found that the area available for outflow increases when IOP and outflow resistance decreases, suggesting a relationship between available area for outflow and outflow resistance. The morphological correlation of reduction in the area available to outflow, with increasing IOP, seems to be related to a progressive collapse of the Schlemm’s canal and a previously unrecognized, progressive herniation of the inner wall and the JCT into the collector channel ostia. A similar herniation of the inner wall into the collector channel ostia was also seen when the eyes were fixed even at 0 mmHg raising the prospect that initially reversible herniations can become irreversible. We hypothesize that the herniations we have documented will be found to be reversible in eyes without glaucoma but can become irreversible, leading to increased outflow resistance and IOP. The results of this study will help us to better understand glaucoma pathophysiology and will also better direct us to the anatomical sites where the pathological resistance resides.
Related Grants
National Glaucoma Research
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego
National Glaucoma Research
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University